B. Kalix

The apolipoprotein ε2 allele and the severity of coronary artery disease in Type 2 diabetic patients

R. James, B. Kalix, M. Meynet, 2001 .

Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects.

A. Golay, R. Munger, R. James, 2000, The American journal of clinical nutrition.

Paraoxonase-1 promoter polymorphism C−107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status

R. James, B. Kalix, S. Bioletto, 2005, Pharmacogenetics and genomics.

Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1

R. James, B. Kalix, M. Blatter-Garin, 2003, Diabetologia.

0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(4):2264–2269 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1295 Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with th

A. Morabia, R. James, B. Kalix, 2005 .

The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients

I. Leviev, B. Kalix, M. Meynet, 2001, Diabetologia.